Literature DB >> 25113270

Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes.

Mathias Hillebrand1, Nathalie Millot, Sara Sheikhzadeh, Meike Rybczynski, Sabine Gerth, Tilo Kölbel, Britta Keyser, Kerstin Kutsche, Peter N Robinson, Jürgen Berger, Thomas S Mir, Tanja Zeller, Stefan Blankenberg, Yskert von Kodolitsch, Britta Goldmann.   

Abstract

BACKGROUND: Total serum transforming growth factor-beta 1 (tsTGF-β1) is increased in patients with Marfan syndrome (MFS), but it has not been assessed in thoracic aortic aneurysm and dissection (TAAD), Loeys-Dietz syndrome (LDS), and bicuspid aortic valve disease (BAVD). HYPOTHESIS: tsTGF-β1 is increased in genetic aortic syndromes including TAAD, LDS, MFS, and BAVD.
METHODS: We measured tsTGF-β1 and performed sequencing of the genes FBN1, TGFBR1, and TGFBR2 in 317 consecutive patients with suspected or known genetic aortic syndrome (167 men, 150 women; mean age 43 ± 14 years). TAAD was diagnosed in 20, LDS in 20, MFS in 128, and BAVD in 30 patients, and genetic aortic syndrome was excluded in 119 patients.
RESULTS: Elevated tsTGF-β1 levels were associated with causative gene mutations (P = 0.008), genetic aortic syndrome (P = 0.009), and sporadic occurrence of genetic aortic syndrome (P = 0.048), whereas only genetic aortic syndrome qualified as an independent predictor of tsTGF-β1 (P = 0.001). The tsTGF-β1 levels were elevated in FBN1 and NOTCH1 mutations vs patients without mutations (both P = 0.004), and in NOTCH1 mutations vs ACTA2/MYH11 mutations (P = 0.015). Similarly, tsTGF-β1 levels were elevated in MFS (P = 0.003) and in BAVD (P = 0.006) vs patients without genetic aortic syndrome. In contrast to specific clinical features of MFS, FBN1 in-frame mutations (P = 0.019) were associated with increased tsTGF-β1 levels.
CONCLUSIONS: tsTGF-β1 is elevated in the entire spectrum of genetic aortic syndromes. However, gradual differences in the increases of tsTGF-β1 levels may mirror different degrees of alteration of tsTGF-β1 signaling in different genetic aortic syndromes.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113270      PMCID: PMC6649456          DOI: 10.1002/clc.22320

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  30 in total

1.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 2.  Recommendations for chamber quantification.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack Shanewise; Scott Solomon; Kirk T Spencer; Martin St John Sutton; William Stewart
Journal:  Eur J Echocardiogr       Date:  2006-02-02

3.  Angiotensin II blockade in Marfan's syndrome.

Authors:  Anna A Ahimastos; Anthony M Dart; Bronwyn A Kingwell
Journal:  N Engl J Med       Date:  2008-10-16       Impact factor: 91.245

4.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

5.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

6.  Augmentation index relates to progression of aortic disease in adults with Marfan syndrome.

Authors:  Kai Mortensen; Muhammet A Aydin; Meike Rybczynski; Johannes Baulmann; Nazila Abdul Schahidi; Georgina Kean; Kristine Kühne; Alexander M J Bernhardt; Olaf Franzen; Thomas Mir; Christian Habermann; Dietmar Koschyk; Rodolfo Ventura; Stephan Willems; Peter N Robinson; Jürgen Berger; Hermann Reichenspurner; Thomas Meinertz; Yskert von Kodolitsch
Journal:  Am J Hypertens       Date:  2009-07-02       Impact factor: 2.689

7.  Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.

Authors:  Anna A Ahimastos; Anuradha Aggarwal; Kellie M D'Orsa; Melissa F Formosa; Anthony J White; Ravi Savarirayan; Anthony M Dart; Bronwyn A Kingwell
Journal:  JAMA       Date:  2007-10-03       Impact factor: 56.272

8.  Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.

Authors:  Delphine Gomez; Ayman Al Haj Zen; Luciano F Borges; Monique Philippe; Paulo Sampaio Gutierrez; Guillaume Jondeau; Jean-Baptiste Michel; Roger Vranckx
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

9.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Authors:  L Faivre; G Collod-Beroud; B L Loeys; A Child; C Binquet; E Gautier; B Callewaert; E Arbustini; K Mayer; M Arslan-Kirchner; A Kiotsekoglou; P Comeglio; N Marziliano; H C Dietz; D Halliday; C Beroud; C Bonithon-Kopp; M Claustres; C Muti; H Plauchu; P N Robinson; L C Adès; A Biggin; B Benetts; M Brett; K J Holman; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

10.  The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome.

Authors:  Meike Rybczynski; Alexander M J Bernhardt; Uwe Rehder; Bettina Fuisting; Ludwig Meiss; Ursula Voss; Christian Habermann; Christian Detter; Peter N Robinson; Mine Arslan-Kirchner; Jörg Schmidtke; Thomas S Mir; Jürgen Berger; Thomas Meinertz; Yskert von Kodolitsch
Journal:  Am J Med Genet A       Date:  2008-12-15       Impact factor: 2.802

View more
  17 in total

1.  Molecular mechanisms of inherited thoracic aortic disease - from gene variant to surgical aneurysm.

Authors:  Elizabeth Robertson; Candice Dilworth; Yaxin Lu; Brett Hambly; Richmond Jeremy
Journal:  Biophys Rev       Date:  2014-12-06

Review 2.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 3.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

4.  Blood Plasma TGF- β1 Concentration in Sporadic Dilatative Pathology of Ascending Aorta: More Questions than Answers.

Authors:  Ramune Sepetiene; Vaiva Patamsyte; Giedrius Zukovas; Giedre Jariene; Zita Stanioniene; Rimantas Benetis; Vaiva Lesauskaite
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

Review 5.  Marfan syndrome: current perspectives.

Authors:  Guglielmina Pepe; Betti Giusti; Elena Sticchi; Rosanna Abbate; Gian Franco Gensini; Stefano Nistri
Journal:  Appl Clin Genet       Date:  2016-05-09

Review 6.  Pathogenic Mechanisms of Bicuspid Aortic Valve Aortopathy.

Authors:  Noor M Yassine; Jasmine T Shahram; Simon C Body
Journal:  Front Physiol       Date:  2017-09-25       Impact factor: 4.566

Review 7.  Update in Biomolecular and Genetic Bases of Bicuspid Aortopathy.

Authors:  Alejandro Junco-Vicente; Álvaro Del Río-García; María Martín; Isabel Rodríguez
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

8.  Evidence of Aortopathy in Mice with Haploinsufficiency of Notch1 in Nos3-Null Background.

Authors:  Sara N Koenig; Kevin M Bosse; Holly A Nadorlik; Brenda Lilly; Vidu Garg
Journal:  J Cardiovasc Dev Dis       Date:  2015

9.  A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta.

Authors:  Anne Leclercq; Véronique Veillat; Sandrine Loriot; Pirjo Spuul; Francesco Madonna; Xavier Roques; Elisabeth Génot
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

Review 10.  Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?

Authors:  Vera van de Pol; Kondababu Kurakula; Marco C DeRuiter; Marie-José Goumans
Journal:  Front Physiol       Date:  2017-11-30       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.